Strategic partnerships Almac Group operates globally with a broad ecosystem of services spanning biomarker development, API and pharmaceutical development, analytical and clinical trial supply, and commercial manufacturing. This presents opportunities to cross-sell integrated CRO/CMO services to existing clients and attract new partners seeking end-to-end drug development, companion diagnostics, and global supply chain capabilities.

Clinical trial tech Almac has recognized awards for Clinical Trial Technology Solutions and offers technologies such as randomisation and trial supply management, eCOA, and data integration. This positions them to upsell advanced trial tech platforms to pharmaceutical companies seeking improved trial efficiency, patient engagement, and biostatistical support across global studies.

Biomarker leadership With biomarker discovery, companion diagnostic development, and CLIA-lab capabilities, Almac can target biopharma groups pursuing precision medicine, diagnostic co-development, and regulatory-ready biomarker workups, including integration with trial designs and regulatory submissions, expanding opportunities in oncology and personalized therapies.

Global delivery Almac’s extensive global footprint and end-to-end services for clinical supply and commercial manufacturing suggest a compelling value proposition for multinational sponsors needing scalable, compliant, and time-sensitive supply chains, packaging, and distribution across regions, enhancing sales potential for large-scale programs.

Recognition & partnerships Recent CSP certification from Olink and industry awards for Clinical Trial Technology Solution Provider signal credibility and innovation leadership. This can be leveraged in sales motions to win new contracts, expand existing accounts, and partner with pharma companies seeking validated, high-trust collaborators.